{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:52:03Z","timestamp":1785009123811,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jtct.2023.10.020","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T15:16:02Z","timestamp":1698678962000},"page":"107-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Disparity in HLA Typing Rates Among Hospitalized Pediatric Patients with Sickle Cell Disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Arrey-Takor","family":"Ayuk-Arrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7723-8936","authenticated-orcid":false,"given":"Olufunke Y.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8390-953X","authenticated-orcid":false,"given":"Isha","family":"Darbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2019-0887","authenticated-orcid":false,"given":"Allistair","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4277-7523","authenticated-orcid":false,"given":"Robert Sheppard","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.10.020_bib0001","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.020_bib0002","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/ajh.25202","article-title":"Clustering of end-organ disease and earlier mortality in adults with sickle cell disease: a retrospective-prospective cohort study","volume":"93","author":"Chaturvedi","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2023.10.020_bib0003","article-title":"Creating an automated contemporaneous cohort in sickle cell anemia to predict survival after disease-modifying therapy","author":"Cronin","year":"202373775","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.10.020_bib0004","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2022.282098","article-title":"Severity and burden of sickle cell disease in France: a nationwide real-world study","author":"Brousse","year":"20231082476","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.10.020_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.15374","article-title":"Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease","volume":"2","author":"Lubeck","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtct.2023.10.020_bib0006","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.020_bib0007","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3324\/haematol.2018.213207","article-title":"Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France","volume":"105","author":"Bernaudin","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.10.020_bib0008","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjh.17311","article-title":"Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres","volume":"192","author":"Alzahrani","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.10.020_bib0009","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199608083350601","article-title":"Bone marrow transplantation for sickle cell disease","volume":"335","author":"Walters","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.10.020_bib0010","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood-2014-05-575209","article-title":"The ethics of a proposed study of hematopoietic stem cell transplant for children with \"less severe\" sickle cell disease","volume":"124","author":"Nickel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.020_bib0011","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbmt.2015.10.017","article-title":"Indications and results of HLA-identical sibling hematopoietic cell transplantation for sickle cell disease","volume":"22","author":"Walters","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.020_bib0012","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3324\/haematol.2013.099747","article-title":"Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel","volume":"99","author":"Angelucci","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.10.020_bib0013","first-page":"100","article-title":"Barriers to bone marrow transplantation for sickle cell anemia","volume":"2","author":"Walters","year":"1996","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.020_bib0014","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.bbmt.2019.06.012","article-title":"Inferior access to allogeneic transplant in disadvantaged populations: a Center for International Blood and Marrow Transplant Research analysis","volume":"25","author":"Paulson","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.020_bib0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.jtct.2023.10.020_bib0016","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible - The Neighborhood Atlas","volume":"378","author":"Kind","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.10.020_bib0017","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/MPH.0000000000000147","article-title":"Pediatric hematology providers on referral for transplant evaluation for sickle cell disease: a regional perspective","volume":"36","author":"Mikles","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.10.020_bib0018","doi-asserted-by":"crossref","first-page":"e28861","DOI":"10.1002\/pbc.28861","article-title":"Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist\/oncologists' practice focus: a Sickle Cell Transplant Advocacy and Research Alliance (STAR) study","volume":"68","author":"Meier","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.10.020_bib0019","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/bjh.16248","article-title":"Paediatric haematologists' attitudes regarding haematopoietic cell transplantation as treatment for sickle cell disease","volume":"188","author":"Stallings","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.10.020_bib0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/pbc.23304","article-title":"Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions","volume":"58","author":"Hansbury","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.10.020_bib0021","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1182\/blood.2020006252","article-title":"Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis","volume":"137","author":"Bona","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.020_bib0022","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbmt.2017.08.034","article-title":"Ethical challenges in hematopoietic cell transplantation for sickle cell disease","volume":"24","author":"Nickel","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.020_bib0023","doi-asserted-by":"crossref","first-page":"e27105","DOI":"10.1002\/pbc.27105","article-title":"Access to hematopoietic stem cell transplant for patients with sickle cell anemia","volume":"65","author":"Meier","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.10.020_bib0024","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MPH.0000000000001433","article-title":"Parent and guardian knowledge of hematopoietic cell transplantation as a treatment option for sickle cell disease","volume":"41","author":"Stallings","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.10.020_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2018.05.019","article-title":"Targeted hydroxyurea education after an emergency department visit increases hydroxyurea use in children with sickle cell anemia","volume":"201","author":"Pecker","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.jtct.2023.10.020_bib0026","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(19)30154-1","article-title":"Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study","volume":"6","author":"Eapen","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2023.10.020_bib0027","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S2352-3026(19)30031-6","article-title":"Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial","volume":"6","author":"Bola\u00f1os-Meade","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2023.10.020_bib0028","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbmt.2018.11.027","article-title":"Haploidentical bone marrow transplantation with post-transplantation cyclophosphamide plus thiotepa improves donor engraftment in patients with sickle cell anemia: results of an International Learning Collaborative","volume":"25","author":"de la Fuente","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.020_bib0029","first-page":"3894","article-title":"Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease","volume":"4","author":"Ngwube","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.10.020_bib0030","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bbmt.2017.05.027","article-title":"Unrelated umbilical cord blood transplantation for sickle cell disease following reduced-intensity conditioning: results of a phase I trial","volume":"23","author":"Abraham","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.020_bib0031","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2117175","article-title":"Biologic and clinical efficacy of lentiglobin for sickle cell disease","volume":"386","author":"Kanter","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.10.020_bib0032","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.10.020_bib0033","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.bbmt.2019.02.011","article-title":"Nonmyeloablative matched sibling donor hematopoietic cell transplantation in children and adolescents with sickle cell disease","volume":"25","author":"Guilcher","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.020_bib0034","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/ajh.24183","article-title":"Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies","volume":"90","author":"King","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2023.10.020_bib0035","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtct.2022.09.020","article-title":"The ASTCT-NMDP ACCESS Initiative: A collaboration to address and sustain equal outcomes for all across the hematopoietic cell transplantation and cellular therapy ecosystem","volume":"28","author":"Auletta","year":"2022","journal-title":"Transplant Cell Ther"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672301641X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672301641X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:12:29Z","timestamp":1763003549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672301641X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S266663672301641X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.10.020","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparity in HLA Typing Rates Among Hospitalized Pediatric Patients with Sickle Cell Disease","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}